Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Dare Bioscience (DARE) Assets Average (2016 - 2025)

Historic Assets Average for Dare Bioscience (DARE) over the last 10 years, with Q3 2025 value amounting to $21.9 million.

  • Dare Bioscience's Assets Average rose 495.15% to $21.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.9 million, marking a year-over-year increase of 495.15%. This contributed to the annual value of $21.7 million for FY2024, which is 3336.77% down from last year.
  • Latest data reveals that Dare Bioscience reported Assets Average of $21.9 million as of Q3 2025, which was up 495.15% from $15.8 million recorded in Q2 2025.
  • In the past 5 years, Dare Bioscience's Assets Average ranged from a high of $52.5 million in Q1 2022 and a low of $9.0 million during Q1 2021
  • Over the past 5 years, Dare Bioscience's median Assets Average value was $23.2 million (recorded in 2023), while the average stood at $29.1 million.
  • Its Assets Average has fluctuated over the past 5 years, first surged by 58771.71% in 2021, then plummeted by 5377.61% in 2024.
  • Dare Bioscience's Assets Average (Quarter) stood at $52.3 million in 2021, then fell by 9.96% to $47.1 million in 2022, then crashed by 50.81% to $23.2 million in 2023, then fell by 13.33% to $20.1 million in 2024, then rose by 8.88% to $21.9 million in 2025.
  • Its Assets Average stands at $21.9 million for Q3 2025, versus $15.8 million for Q2 2025 and $20.4 million for Q1 2025.